Page last updated: 2024-10-30

mephenytoin and Carcinoma, Oat Cell

mephenytoin has been researched along with Carcinoma, Oat Cell in 1 studies

Mephenytoin: An anticonvulsant effective in tonic-clonic epilepsy (EPILEPSY, TONIC-CLONIC). It may cause blood dyscrasias.
mephenytoin : An imidazolidine-2,4-dione (hydantoin) in which the imidazolidine nucleus carries a methyl group at N-3 and has ethyl and phenyl substituents at C-5. An anticonvulsant, it is no longer available in the USA or the UK but is still studied largely because of its interesting hydroxylation polymorphism.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benhamou, S1
Bouchardy, C1
Dayer, P1

Other Studies

1 other study available for mephenytoin and Carcinoma, Oat Cell

ArticleYear
Lung cancer risk in relation to mephenytoin hydroxylation activity.
    Pharmacogenetics, 1997, Volume: 7, Issue:2

    Topics: Adult; Aryl Hydrocarbon Hydroxylases; Carcinoma; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Ca

1997